World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
7050
World Ranking
4639
National Ranking
2088

C. David Pauza publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where C. David Pauza sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 175 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

C. David Pauza D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where C. David Pauza sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

C. David Pauza is affiliated with the University of Maryland, Baltimore in the United States. The research encompasses several interconnected fields, primarily within medicine, biochemistry, genetics, and molecular biology with significant work also classified under immunology and microbiology.

The main subfields of study include molecular biology, immunology, oncology, virology, and hematology. Key research topics focus on immune cell function and interaction, CAR-T cell therapy research, HIV research and treatment, monoclonal and polyclonal antibodies research, glycosylation and glycoproteins research, transgenic plants and applications, and CRISPR and genetic engineering.

Selected recent publications by the scientist include:

  • "FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection," 2021, The Journal of Immunology
  • "Advances in cell and gene therapy for HIV disease: it is good to be specific," 2021, Current Opinion in HIV and AIDS
  • "Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, Lentivirus-Modified CD4 T Cells for HIV Functional Cure," 2020, Molecular Therapy - Methods & Clinical Development
  • "Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial," 2022, Frontiers in Medicine
  • "Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models," 2022, Frontiers in Immunology

Frequent coauthors include Haishan Li, Tyler Lahusen, José Bordón, Lingzhi Xiao, and Nidal Muvarak, indicating collaborations spanning various aspects of immunology and cell therapy research.

Publication venues reflect multidisciplinary interests, such as:

  • The Journal of Immunology
  • Current Opinion in HIV and AIDS
  • Molecular Therapy - Methods & Clinical Development
  • Frontiers in Medicine
  • Frontiers in Immunology

Best Publications

  • Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.

    C Terai;R S Kornbluth;C D Pauza;D D Richman

  • Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

    David T. Evans;David T. Evans;David H. O'Connor;Peicheng Jing;John L. Dzuris

  • Human γδ T lymphocytes induce robust NK cell mediated antitumor cytotoxicity through CD137 engagement

    Amudhan Maniar;Xiaoyu Zhang;Wei Lin;Brian R. Gastman

  • Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism

    A V Moses;F E Bloom;C D Pauza;J A Nelson

  • Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques

    C. David Pauza;Parul Trivedi;Matthew Wallace;Tracy J.Tracy Ruckwardt

  • Isopentenyl Pyrophosphate–Activated CD56+ γδ T Lymphocytes Display Potent Antitumor Activity toward Human Squamous Cell Carcinoma

    Alan A.Z. Alexander;Amudhan Maniar;Jean Saville Cummings;Andrew M. Hebbeler

  • Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis.

    Unknown

  • Monocytes Treated with Human Immunodeficiency Virus Tat Kill Uninfected CD4+ Cells by a Tumor Necrosis Factor-Related Apoptosis-Induced Ligand-Mediated Mechanism

    Yida Yang;Ilia Tikhonov;Tracy J. Ruckwardt;Mahmoud Djavani

  • Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions

    Lin Li;Hai Shan Li;Hai Shan Li;C David Pauza;Michael Bukrinsky

  • Rhesus Macaques That Become Systemically Infected With Pathogenic SHIV 89.6-PD After Intravenous, Rectal, or Vaginal Inoculation and Fail to Make an Antiviral Antibody Response Rapidly Develop AIDS

    Yichen Lu;C. D. Pauza;Xusheng Lu;D. C. Montefiori

  • A Neonatal Fc Receptor-Targeted Mucosal Vaccine Strategy Effectively Induces HIV-1 Antigen-Specific Immunity to Genital Infection

    Li Lu;Senthilkumar Palaniyandi;Rongyu Zeng;Yu Bai

  • Characterization of Primary Isolate-Like Variants of Simian-Human Immunodeficiency Virus

    John M. Crawford;Patricia L. Earl;Bernard Moss;Keith A. Reimann

  • Definition of Five New Simian Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitopes and Their Restricting Major Histocompatibility Complex Class I Molecules: Evidence for an Influence on Disease Progression

    D. T. Evans;P. Jing;T. M. Allen;D. H. O'Connor

  • Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.

    Unknown

  • Two bases are deleted from the termini of HIV-1 linear DNA during integrative recombination.

    C. David Pauza

  • Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections.

    M. Wallace;A. M. Scharko;C. D. Pauza;P. Fisch;P. Fisch

  • Gamma Interferon Secretion by Human Vγ2Vδ2 T Cells after Stimulation with Antibody against the T-Cell Receptor plus the Toll-Like Receptor 2 Agonist Pam3Cys

    Carl O. Deetz;Carl O. Deetz;Andrew M. Hebbeler;Andrew M. Hebbeler;Nadia A. Propp;Cristiana Cairo

  • In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vγ2-Jγ1.2/Vδ2 T-cell receptors

    Peter S. Evans;Patrick J. Enders;Cheng Cameron Yin;Tracy J. Ruckwardt

  • Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local.

    C. David Pauza;Mei-Ling Liou;Tyler Lahusen;Lingzhi Xiao

  • Whole-body positron emission tomography in patients with HIV-1 infection.

    Alexander M Scharko;Scott B Perlman;Robert W Pyzalski;Franklin M Graziano

  • γδ T Cells in HIV Disease: Past, Present, and Future

    C. David Pauza;Bhawna Poonia;Haishan Li;Cristiana Cairo

  • Early blood profiles of virus infection in a monkey model for Lassa fever.

    Mahmoud M. Djavani;Oswald R. Crasta;Juan Carlos Zapata;Zhangjun Fei

  • Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment.

    Bruce L Gilliam;Alonso Heredia;Anthony DeVico;Nhut Le

Frequent Co-Authors

Robert R. Redfield
Robert R. Redfield Centers for Disease Control and Prevention
Vittorio Colizzi
Vittorio Colizzi University of Rome Tor Vergata
David C. Montefiori
David C. Montefiori Duke University
Ko Okumura
Ko Okumura Juntendo University
Hideo Yagita
Hideo Yagita Juntendo University
Pierre Hainaut
Pierre Hainaut Grenoble Alpes University
William A. Blattner
William A. Blattner University of Maryland, Baltimore
Renato Franco
Renato Franco University of Campania "Luigi Vanvitelli"
Franco M. Buonaguro
Franco M. Buonaguro MRC Laboratory of Molecular Biology
Daniel N. Streblow
Daniel N. Streblow Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing advanced nursing degrees online can be a strategic move. Programs like the cheapest online pmhnp programs offer cost-effective routes for specializing in psychiatric mental health, complementing immunology knowledge by addressing immune-related mental health issues.

Nursing professionals aiming to elevate their careers should consider the highest paid dnp specialties. These specialties provide lucrative opportunities that often align with advanced understanding of immune system diseases, enhancing both clinical impact and earning potential.

Transitioning from a Family Nurse Practitioner (FNP) to more intensive fields is also viable. Resources like fnp to acute care np outline crucial steps for this career shift, benefiting those who wish to engage in acute immune-related conditions requiring specialized nursing care.

Finally, accelerated pathways such as those highlighted by the accelerated np program guide enable candidates to achieve nurse practitioner status rapidly. These fast-tracked options are ideal for professionals eager to integrate immunology insights into clinical practice sooner.

Best Scientists Citing C. David Pauza

Trending Scientists

Recently Published Articles